Trial Profile
Clinical study on Tolerability, pharmacodynamics and pharmacokinetics of multiple doses of Albuvirtide injection in HIV-infected patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Labuvirtide (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 21 May 2012 Actual end date changed from 1 Jun 2011 to 31 Aug 20111 as reported by Chinese Clinical Trial Register.
- 19 Sep 2011 New trial record